Literature DB >> 3801368

Extended retinal tamponade in the treatment of retinal detachment with proliferative vitreoretinopathy.

W H Stern, R N Johnson, A R Irvine, M E Barricks, B S Boyden, G F Hilton, L I Lonn, A Schwartz.   

Abstract

We have used intraocular sulphur hexafluoride or liquid silicone as an adjunct to vitreous surgery in the treatment of a non-randomised sequential series of 19 eyes with retinal detachment complicated by proliferative vitreoretinopathy. We have studied the surgical results and complications of these two tamponades and drawn preliminary conclusions on their use in retinal reattachment surgery. After a seven-month minimum follow-up 13 (68%) of the eyes have reattached retinas. Six (60%) of 10 eyes treated only with silicone have reattached retinas, and four (67%) of six eyes treated only with sulphur hexafluoride gas tamponade have reattached retinas. An additional three eyes treated initially with silicone oil subsequently developed retinal detachments; all were successfully reattached with sulphur hexafluoride tamponade after silicone oil removal. Intraoperative pneumatic retinal reattachment to assess relief of retinal traction combined with the production of widespread chorioretinal adhesions to wall off persistent anterior traction and detachment, as well as extended postoperative gas tamponade of the retina, appears to enhance the surgical results in retinal detachment complicated by proliferative vitreoretinopathy. Silicone oil tamponade of the retina appears to be useful in cases where retinal traction cannot be entirely relieved and in patients who are unable to tolerate the head positioning required for effective gas tamponade of the retina. A controlled clinical study recently begun will be required to define further the precise role of these methods of retinal tamponade.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801368      PMCID: PMC1040860          DOI: 10.1136/bjo.70.12.911

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  The use of liquid silicone in retinal detachment surgery.

Authors:  P A CIBIS; B BECKER; E OKUN; S CANAAN
Journal:  Arch Ophthalmol       Date:  1962-11

2.  Treatment of the detached immobile retina.

Authors:  J D Scott
Journal:  Trans Ophthalmol Soc U K       Date:  1972

3.  [Use of intraocular silicone after vitrectomy as treatment of massive retractions of the vitreous body (preliminary note)].

Authors:  J Haut; M Ullern; M L Boulard; A Cedah
Journal:  Bull Soc Ophtalmol Fr       Date:  1978 Apr-May

4.  Glial cell proliferation in human retinal detachment with massive periretinal proliferation.

Authors:  D L Van Horn; T M Aaberg; R Machemer; R Fenzl
Journal:  Am J Ophthalmol       Date:  1977-09       Impact factor: 5.258

5.  Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation.

Authors:  R Machemer; D van Horn; T M Aaberg
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

6.  Macular abnormalities in the reattached retina.

Authors:  P E Cleary; P K Leaver
Journal:  Br J Ophthalmol       Date:  1978-09       Impact factor: 4.638

7.  The optics of vitreous surgery.

Authors:  M B Landers; E Stefánsson; M L Wolbarsht
Journal:  Am J Ophthalmol       Date:  1981-05       Impact factor: 5.258

8.  Epidemiology of retinal detachment.

Authors:  M H Haimann; T C Burton; C K Brown
Journal:  Arch Ophthalmol       Date:  1982-02

9.  Retinotomy.

Authors:  R Machemer
Journal:  Am J Ophthalmol       Date:  1981-12       Impact factor: 5.258

10.  Silicone oil in the treatment of massive preretinal retraction. I. Results in 105 eyes.

Authors:  R H Grey; P K Leaver
Journal:  Br J Ophthalmol       Date:  1979-05       Impact factor: 4.638

View more
  1 in total

1.  Deposition of silicone oil droplets in the residual anterior lens capsule after vitrectomy and lensectomy in rabbits.

Authors:  T Miyamoto; S Saika; A Yamanaka; Y Okada; Y Ohnishi
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.